Randomized trial comparing terazosin 5 mg daily and doxazosin GITS [gastrointestinal therapeutic system] 4 mg daily in the successful rate of trial without catheter in acute urinary retention with long term follow up.

Trial Profile

Randomized trial comparing terazosin 5 mg daily and doxazosin GITS [gastrointestinal therapeutic system] 4 mg daily in the successful rate of trial without catheter in acute urinary retention with long term follow up.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 15 Dec 2008

At a glance

  • Drugs Doxazosin (Primary) ; Terazosin (Primary)
  • Indications Urinary retention
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Dec 2008 Primary outcome amended as reported by ClinicalTrials.gov.
    • 13 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top